Hyperopic photorefractive keratectomy with adjunctive topical mitomycin C for refractive error after penetrating keratoplasty for keratoconus.
OBJECTIVE
To present a case of photorefractive keratectomy (PRK) with adjunctive topical mitomycin C (MMC) in an anisometropic hyperopic patient after penetrating keratoplasty (PKP) for keratoconus.


METHODS
Interventional case report, chart review, and literature review.


RESULTS
A 43-year-old man with a refraction of +7.00 -4.75 x 125 in the right eye underwent PRK 10 months after PKP for keratoconus. The patient had sutures removed for 3 months and was intolerant of contact lenses. After photoablation, 0.02% MMC was applied to the corneal stromal bed. The patient was followed up daily until the epithelium closed and at 1 week, 1 month, 3 months, and 6 months postoperatively.


CONCLUSIONS
To our knowledge, this represents the first reported case of the use of MMC to prevent postoperative haze after PRK for PKP in an eye with keratoconus. MMC (0.02%) applied topically to the cornea immediately after PRK is safe and effective to treat a hyperopic refractive error after PKP and prevent postoperative corneal haze formation without the risks of performing a lamellar flap into an ectatic corneal bed.
Solomon
Renée
R
Ophthalmic Consultants of Long Island (R.S., E.D.D., H.D.P.), Rockville Centre, NY 11570, USA.
Donnenfeld
Eric D
ED
Thimons
James
J
Stein
Jonathan
J
Perry
Henry D
HD
D000287:Administration, Topical; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003318:Corneal Opacity / Q000517:prevention & control; D006801:Humans; D006956:Hyperopia / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D007640:Keratoconus / Q000601:surgery*; D015948:Keratoplasty, Penetrating / Q000009:adverse effects*; D054018:Lasers, Excimer; D008297:Male; D016685:Mitomycin / Q000627:therapeutic use*; D018903:Photorefractive Keratectomy
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin